Device Trial Radar · NCT00448006
Clinical Feasibility Study of Allium's Biliary Stent
Last checked: Nov 20, 2026Latest source record: Jul 10, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- Allium, Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 15, 2007
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and efficacy of the Allium Biliary Stent in malignant obstructions of the common bile duct.
Conditions
- Malignant Obstruction of the Common Bile Duct
Interventions
Allium Biliary StentDevice
device
allium biliary stentDevice
allium biliary stent
Primary outcomes
What the sponsor says the trial is designed to measure.
- Body temperature measurement, patient comfort analysis, sonographic measurements of the duct channels, abdominal X-ray imaging of the stent, and blood tests will be performed at 24 hours, 30 days, 3, 6, and 12 months following stent insertion.Time frame: up to 12 months follow up
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Sheba Medical Center
Ramat Gan, Israel
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.